Full-line orthopedic biologics · Texas & Central U.S.
Texas Regenerative Supply puts the full biologics portfolio on the back table for spine, trauma, foot & ankle, sports, and joint cases, then measures what happens next. As a member of the Osselytics network, we turn routine case documentation into de-identified evidence that surgeons, facilities, and manufacturers can act on.
Most biologics reps carry one manufacturer's catalog and fit every case to it. We carry the category. That lets us match the graft to the defect, the patient, the site of service, and the reimbursement, rather than the other way around.
Then we close the loop. Each case we cover is logged by product, lot, procedure, and site of service, with outcomes followed at set intervals. Over time, a facility knows exactly what it is using, what it costs per case, and what it is getting for it.
The portfolio
We source from multiple manufacturers in every category, so the back table is built around clinical need and facility economics.
Fibers, putties, chips, strips, and structural allograft for fusion, void fill, and revision.
Allografts that retain native cellular components for challenging fusion and nonunion cases.
Calcium phosphate, bioactive glass, and composite options with predictable handling and resorption.
Collagen carriers, sponges, and matrices that deliver graft material where it is needed.
Barrier and wound-covering membranes for soft-tissue repair and surgical sites.
Point-of-care platelet-rich plasma systems for clinics, ORs, and facility programs, stocked locally.
Select foot & ankle, sports-medicine, and joint implants, plus post-op recovery products, billed direct from the manufacturer with no distributor markup.
Product availability, indications, and regulatory status vary by manufacturer. All products are used according to labeling and surgeon judgment.
Member of the Osselytics network
Osselytics is the AI analytics platform behind our cases. Each month it compiles structured, de-identified case data into cost comparisons, case-profitability reporting, and real-world-evidence summaries. Here is exactly how we use it.
Product, lot and UDI, procedure, CPT, surgeon, site of service, and total case cost are recorded on a standard utilization form and tied to the patient MRN in the facility’s records.
Repeatable follow-up fields at defined windows, such as union or fusion status, complications, and revisions, make cases comparable across surgeons and sites.
Every month, the Osselytics AI platform compiles cases into procedure mix, utilization, cost per case, and cost comparisons across products, surgeons, and facilities.
A monthly report covers case profitability and practical alternatives that can grow revenue and surgeon satisfaction. Manufacturers receive aggregate real-world evidence.
Case economics
We don’t mark up implants. The manufacturer bills the facility directly, and we account for the full cost of each case so the facility can see exactly where its margin goes.
Implants are invoiced by the manufacturer to the facility at contract price. No distributor markup sits between the two.
Implants, biologics, and lot/UDI records roll up to one case-cost record linked to the patient MRN in the facility’s system for traceability and accounting.
Each month, case data is compiled with cost comparisons across products, surgeons, procedures, and sites of service.
A monthly report on case profitability, with options that can grow facility revenue and surgeon satisfaction.
How we work
We start with current biologics use, procedure mix, payer mix, and contract terms, then map the portfolio to what the facility actually does.
Separate ASC and hospital tracks and clear price files. Implants are billed by the manufacturer directly to the facility, with no distributor markup.
Consignment, bill-and-replace, or stocked purchase, managed from a Texas hub with par levels and expiration tracking.
Local, credentialed coverage on case day, with the same rep following the same surgeon across facilities.
Every implant and biologic in the case, with lot and UDI, rolls up to a total case cost tied to the patient MRN for full traceability and accounting.
Data is compiled monthly through the Osselytics AI platform, with cost comparisons, case profitability, and alternatives that help grow revenue and surgeon satisfaction.
Who we serve
Surgeon-owned and health-system ASCs moving spine, joint, and extremity cases out of the hospital. We bring direct manufacturer implant billing, local inventory, and monthly case-profitability data to share with partners and payers.
Spine, orthopedic trauma, foot & ankle, sports, and joint surgeons who want the right graft for the case and objective feedback on how it performed.
Value-analysis-ready product files, contract compliance, and utilization reporting across sites.
Experienced support for federal accounts and their purchasing and documentation requirements.
A proven Texas and Central U.S. channel with surgeon and facility access, credentialed coverage, and real-world evidence from day one. Independent distributors can also access broader lines through sub-distribution.
Partner with TRS
Coverage
Headquartered in Flower Mound, with case coverage and inventory support in every major Texas market.
Products are recommended within labeling and clinical documentation, never pushed to fill a quota.
Lot and UDI records on every case, ready for recalls, audits, and tissue tracking.
Distribution, data, and physician advisory relationships are contracted separately and kept at fair market value.
Implants are billed direct from the manufacturer, so facilities see true implant cost and total cost per case.
Get started
Tell us who you are and what you are working on. We typically start with a no-cost biologics utilization review.
distribution@texasregasupply.com